Astrana Health (NASDAQ:ASTH) has recently been flagged by a screening process that combines the technical discipline of Mark Minervini’s Trend Template with a fundamental filter for strong growth. The idea is straightforward: find stocks that are not only technically sound, showing a clear, sustained uptrend with solid relative strength, but also possess the earnings and sales momentum that often supports truly explosive moves. By pairing these two lenses, the screen aims to surface companies that are both trending well and delivering the kind of fundamental acceleration that historically precedes big upside. Today, we’re taking a closer look at why Astrana Health is showing up on that radar.
Why it fits the Minervini Trend Template
The Trend Template is a set of eight strict technical criteria designed to isolate stocks in a healthy Stage 2 uptrend. Astrana Health clears every single bar with room to spare. Here’s how it stacks up:
- Price above key moving averages: The stock is trading at $49.17, well above its 50-day SMA ($38.60), 150-day SMA ($29.04), and 200-day SMA ($28.94).
- Moving average alignment: The 50-day is above the 150-day, the 150-day is above the 200-day, and all three are rising—a textbook bullish configuration.
- 52-week range condition: The current price is 172% above its 52-week low of $18.08 and sits within 4.7% of its 52-week high of $51.60. That meets the Minervini requirement of being at least 30% above the low and within 25% of the high.
- Relative strength: The stock has a relative strength score of 96.35, meaning it outperforms 96% of all stocks in the database—well above the 70 threshold Minervini prefers.
These aren’t just a random set of checks. In the Minervini framework, this alignment signals that institutional buyers are in control, momentum is strong, and the stock is set to continue its leadership. A stock that passes all eight criteria has essentially been vetted for both trend quality and near-term strength.
High growth momentum: digging into the fundamentals
The second layer of the screen zeroes in on growth. While the Trend Template handles the technical side, the High Growth Momentum (HGM) rating—currently at 6 out of 10—ensures the company is performing on fundamental cylinders as well. Here are the key numbers that support the growth case:
- Sales growth: Revenue is accelerating across the board. TTM revenue growth is +56.7%, the latest quarter saw +55.6% year-over-year, and estimates for the next quarter point to +53.5%. Even the prior two quarters were strong at +42.9% and +99.7%, respectively.
- Earnings momentum: After a rough patch, earnings per share have turned sharply higher. EPS growth in the most recent quarter came in at +107% year-over-year, following a +180% gain in the prior quarter. Estimates for the next quarter suggest another +76% jump.
- Profit margin improvement: Profit margins have been climbing from near-zero levels. The latest quarter showed a net margin of 1.50%, up from 0.63% in the previous quarter and 0.04% two quarters ago. That’s a clear sign of operating leverage starting to take effect.
- Free cash flow: Free cash flow per share is $3.13, with a one-year growth rate of +255%. Strong cash generation provides flexibility for reinvestment or acquisitions.
Why do these metrics matter for the Minervini approach? Because the strategy is built on the principle that big price moves are almost always preceded by big fundamental improvements. The combination of accelerating sales, surging EPS, and expanding margins is exactly the kind of “earnings surprise” setup Minervini looks for. It’s not enough for a stock to look good on a chart—the business itself must be delivering measurable results.
Technical rating and setup quality summary
The ChartMill Technical Report for Astrana Health assigns a technical rating of 9 out of 10, reflecting outstanding trend health. The long-term and short-term trends are both positive, and the stock is currently making fresh 52-week highs while leading the S&P 500. Volume has been notably stronger in recent days, which typically confirms institutional accumulation.
However, the setup quality rating is just 2 out of 10 at this moment. This isn’t necessarily a negative—it simply means the stock has become extended after its recent surge. For traders following Minervini’s playbook, it may be wise to wait for a pullback or consolidation before entering, as the best risk/reward entries often come after a period of price contraction.
For the full technical breakdown, you can review the complete report here.
Finding more opportunities like Astrana Health
Astrana Health is just one example of the kind of stock that emerges from this combined screen. If you’re looking to build a watchlist of similar candidates—stocks that pass the Minervini Trend Template and carry strong High Growth Momentum ratings—you can run the screen yourself and see the full list of results.
Click here to access the full High Growth Momentum + Trend Template screening results.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Always conduct your own due diligence and consider your risk tolerance before making any trading decisions.
Read full article here »
View the Zacks #1 Rank List
Astrana Health (NASDAQ:ASTH) Screens as a Powerful Minervini Trend Template Stock with High Growth Momentum
Astrana Health (NASDAQ:ASTH) has recently been flagged by a screening process that combines the technical discipline of Mark Minervini’s Trend Template with a fundamental filter for strong growth. The idea is straightforward: find stocks that are not only technically sound, showing a clear, sustained uptrend with solid relative strength, but also possess the earnings and sales momentum that often supports truly explosive moves. By pairing these two lenses, the screen aims to surface companies that are both trending well and delivering the kind of fundamental acceleration that historically precedes big upside. Today, we’re taking a closer look at why Astrana Health is showing up on that radar.
Why it fits the Minervini Trend Template
The Trend Template is a set of eight strict technical criteria designed to isolate stocks in a healthy Stage 2 uptrend. Astrana Health clears every single bar with room to spare. Here’s how it stacks up:
These aren’t just a random set of checks. In the Minervini framework, this alignment signals that institutional buyers are in control, momentum is strong, and the stock is set to continue its leadership. A stock that passes all eight criteria has essentially been vetted for both trend quality and near-term strength.
High growth momentum: digging into the fundamentals
The second layer of the screen zeroes in on growth. While the Trend Template handles the technical side, the High Growth Momentum (HGM) rating—currently at 6 out of 10—ensures the company is performing on fundamental cylinders as well. Here are the key numbers that support the growth case:
Why do these metrics matter for the Minervini approach? Because the strategy is built on the principle that big price moves are almost always preceded by big fundamental improvements. The combination of accelerating sales, surging EPS, and expanding margins is exactly the kind of “earnings surprise” setup Minervini looks for. It’s not enough for a stock to look good on a chart—the business itself must be delivering measurable results.
Technical rating and setup quality summary
The ChartMill Technical Report for Astrana Health assigns a technical rating of 9 out of 10, reflecting outstanding trend health. The long-term and short-term trends are both positive, and the stock is currently making fresh 52-week highs while leading the S&P 500. Volume has been notably stronger in recent days, which typically confirms institutional accumulation.
However, the setup quality rating is just 2 out of 10 at this moment. This isn’t necessarily a negative—it simply means the stock has become extended after its recent surge. For traders following Minervini’s playbook, it may be wise to wait for a pullback or consolidation before entering, as the best risk/reward entries often come after a period of price contraction.
For the full technical breakdown, you can review the complete report here.
Finding more opportunities like Astrana Health
Astrana Health is just one example of the kind of stock that emerges from this combined screen. If you’re looking to build a watchlist of similar candidates—stocks that pass the Minervini Trend Template and carry strong High Growth Momentum ratings—you can run the screen yourself and see the full list of results.
Click here to access the full High Growth Momentum + Trend Template screening results.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Always conduct your own due diligence and consider your risk tolerance before making any trading decisions.
Read full article here »